RAS internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 295 (28), 9335-9348
- https://doi.org/10.1074/jbc.ra119.011080
Abstract
No abstract availableFunding Information
- American Cancer Society (118198-IRG-58-001-52-IRG94)
- HHS | NIH | National Center for Advancing Translational Sciences (8UL1TR000114)
- HHS | NIH | National Institute of General Medical Sciences (P30 GM124165)
This publication has 49 references indexed in Scilit:
- Functional characterisation of a novel class of in-frame insertion variants of KRAS and HRASScientific Reports, 2019
- Optimization of a microfluidics-based next generation sequencing assay for clinical oncology diagnosticsAnnals of Translational Medicine, 2018
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in CancerThe Journal of Molecular Diagnostics, 2017
- Patterns of metastasis in colon and rectal cancerScientific Reports, 2016
- KRAS insertion mutations are oncogenic and exhibit distinct functional propertiesNature Communications, 2016
- COSMIC: exploring the world's knowledge of somatic mutations in human cancerNucleic Acids Research, 2014
- High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancerBMC Cancer, 2013
- Predicting the functional impact of protein mutations: application to cancer genomicsNucleic Acids Research, 2011
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancerThe Lancet Oncology, 2010
- Ras oncogenes and their downstream targetsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007